Resorption of implanted bone prepared from normal and warfarin-treated rats.
AUTOR(ES)
Lian, J B
RESUMO
Bone that was virtually depleted of the vitamin K-dependent protein, osteocalcin, and 93% reduced in the concentration of its characteristic amino acid, gamma-carboxyglutamic acid, was obtained from rats treated with warfarin for 6 wk. Osteocalcin-deficient bone particles were resistant to resorption when implanted subcutaneously in normal rats. The relative resorption was 60% of control bone, as measured by histomorphometry as percent of bone particles in the field. Additionally, the number of multinucleated cells around the bone particles was reduced by 54%. These data suggest that osteocalcin is an essential component for bone matrix to elicit progenitor-cell recruitment and differentiation necessary for bone resorption.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=425136Documentos Relacionados
- Induction of nonspecific tolerance to endotoxins reduces the alveolar bone resorption in ligature-treated rats.
- Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.
- Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.
- Effects of vasopressin on electrolyte transport across isolated colon from normal and dexamethasone-treated rats.
- Formation, mineralization, and resorption of bone in hypophosphatemic rats